NASDAQ:FLGT - Fulgent Genetics Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $55.80
  • Forecasted Upside: 37.91 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$40.46
▲ +3.95 (10.82%)
1 month | 3 months | 12 months
Get New Fulgent Genetics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FLGT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FLGT

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$55.80
▲ +37.91% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Fulgent Genetics in the last 3 months. The average price target is $55.80, with a high forecast of $100.00 and a low forecast of $20.00. The average price target represents a 37.91% upside from the last price of $40.46.
Hold
The current consensus among 5 investment analysts is to hold stock in Fulgent Genetics. This rating changed within the last month from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/5/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/3/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/2/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/1/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/30/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/27/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/26/2020

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/24/2020BTIG ResearchDowngradeBuy ➝ NeutralHigh
i
11/10/2020Piper SandlerBoost Price TargetOverweight$73.00 ➝ $100.00Medium
i
11/1/2020OppenheimerReiterated RatingBuy$75.00High
i
Rating by Kevin DeGeeter at Oppenheimer Holdings Inc.
9/25/2020CSFBBoost Price TargetNeutral$13.00 ➝ $42.00Low
i
9/25/2020Credit Suisse GroupBoost Price TargetNeutral$13.00 ➝ $42.00Medium
i
8/27/2020OppenheimerReiterated RatingBuy$75.00High
i
8/19/2020OppenheimerInitiated CoverageOutperform$75.00High
i
8/17/2020Piper SandlerBoost Price TargetOverweight$68.00 ➝ $73.00High
i
8/5/2020Piper SandlerBoost Price TargetOverweight$31.00 ➝ $68.00High
i
7/27/2020Piper SandlerBoost Price TargetOverweight$21.00 ➝ $31.00High
i
6/17/2020Piper SandlerBoost Price TargetOverweight$18.00 ➝ $21.00High
i
5/29/2020BTIG ResearchInitiated CoverageBuy$20.00High
i
5/5/2020CSFBLower Price TargetNeutral$12.00 ➝ $11.00High
i
5/5/2020Credit Suisse GroupLower Price TargetNeutral$12.00 ➝ $11.00High
i
5/5/2020Piper SandlerBoost Price TargetOverweight$16.50 ➝ $18.00High
i
3/11/2020Piper SandlerBoost Price TargetHigh
i
3/11/2020Credit Suisse GroupReiterated RatingHoldHigh
i
11/5/2019Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$9.50 ➝ $12.30High
i
8/6/2019Piper Jaffray CompaniesBoost Price TargetNeutral$5.30 ➝ $9.50High
i
4/26/2019Credit Suisse GroupDowngradeOutperform ➝ NeutralHigh
i
8/7/2018Piper Jaffray CompaniesReiterated RatingHold$5.10Medium
i
5/9/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$6.00 ➝ $5.00Low
i
3/1/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$6.50 ➝ $6.00High
i
3/1/2018Piper Jaffray CompaniesDowngradeOverweight ➝ NeutralHigh
i
11/7/2017Credit Suisse GroupLower Price TargetOutperform$10.00 ➝ $7.50N/A
i
11/7/2017Raymond JamesDowngradeOutperform ➝ Mkt PerformN/A
i
10/24/2017Piper Jaffray CompaniesReiterated RatingBuyN/A
i
8/9/2017Piper Jaffray CompaniesReiterated RatingOverweight$10.00 ➝ $7.00Low
i
8/8/2017Credit Suisse GroupLower Price TargetOutperform$11.00 ➝ $10.00High
i
11/4/2016Credit Suisse GroupReiterated RatingBuy$13.00N/A
i
10/24/2016Credit Suisse GroupInitiated CoverageOutperform$13.00N/A
i
10/24/2016BTIG ResearchInitiated CoverageBuy$15.00N/A
i
10/24/2016Piper Jaffray CompaniesInitiated CoverageOverweight$13.00N/A
i
(Data available from 11/27/2015 forward)
Fulgent Genetics logo
Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Read More

Today's Range

Now: $40.46
$36.70
$40.56

50 Day Range

MA: $38.57
$31.01
$46.05

52 Week Range

Now: $40.46
$6.70
$52.47

Volume

33,298 shs

Average Volume

666,263 shs

Market Capitalization

$982.13 million

P/E Ratio

337.19

Dividend Yield

N/A

Beta

1.75